We are live on ! Find out more
EIDX

Eidos Therapeutics, Inc. Common Stock
EIDX

Delisted

EIDX was delisted on the 25th of January, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Eidos Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 120 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 121 → 0 (-121)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $1.45B → $0 (-$1.45B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 120

Holders
–
Holders Change
-121
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
120
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$205M
2
ACM
Aisling Capital Management
New York
-$148M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$119M
4
PA
Perceptive Advisors
New York
-$90.4M
5
MF
Magnetar Financial
Illinois
-$78.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
– -$205M -1,557,225 Closed
ACM
2
Aisling Capital Management
New York
– -$148M -1,123,630 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$119M -905,343 Closed
PA
4
Perceptive Advisors
New York
– -$90.4M -686,922 Closed
MF
5
Magnetar Financial
Illinois
– -$78.9M -599,330 Closed
RG
6
Redmile Group
California
– -$59.5M -452,295 Closed
GGHC
7
Gilder Gagnon Howe & Co
New York
– -$43.8M -333,176 Closed
EAM
8
Eventide Asset Management
Massachusetts
– -$41.8M -317,417 Closed
OM
9
Opaleye Management
Massachusetts
– -$41.5M -315,550 Closed
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
– -$39.1M -297,182 Closed
AA
11
AQR Arbitrage
Connecticut
– -$36.2M -274,853 Closed
BOTOTLSJU
12
Board of Trustees of The Leland Stanford Junior University
California
– -$35M -265,670 Closed
DAM
13
DLD Asset Management
New York
– -$31.5M -239,762 Closed
AAA
14
Affinity Asset Advisors
New York
– -$29.6M -225,000 Closed
State Street
15
State Street
Massachusetts
– -$28.4M -215,507 Closed
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
– -$27.8M -211,102 Closed
AIG
17
American International Group
New York
– -$27.2K -206,358 Closed
AAM
18
Alpine Associates Management
Florida
– -$24.2M -184,221 Closed
Geode Capital Management
19
Geode Capital Management
Massachusetts
– -$24.1M -183,207 Closed
Lord, Abbett & Co
20
Lord, Abbett & Co
New Jersey
– -$23.5M -178,608 Closed
HA
21
HHLR Advisors
Cayman Islands
– -$23.5M -178,600 Closed
Tudor Investment Corp
22
Tudor Investment Corp
Connecticut
– -$20.5M -155,671 Closed
Goldman Sachs
23
Goldman Sachs
New York
– -$19.4M -147,421 Closed
SCC
24
Spring Creek Capital
Kansas
– -$18.4M -140,000 Closed
Northern Trust
25
Northern Trust
Illinois
– -$17.9M -136,117 Closed
1
2 3 4 5

EIDX Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Eidos Therapeutics, Inc. Common Stock (EIDX) for Q1 2021, worth a combined $0 — down 100% from $1.45B a quarter earlier.

Sellers outnumbered buyers: 120 funds closed out of EIDX and 0 opened new positions — a net loss of 120 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $205M sold.

  • 0 institutional investors held Eidos Therapeutics, Inc. Common Stock (EIDX) as of Q1 2021, down from 121 in Q4 2020.
  • Funds reported $0 of Eidos Therapeutics, Inc. Common Stock stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Eidos Therapeutics, Inc. Common Stock positions in Q1 2021 and 120 closed out, a net change of -120 holders.
  • The largest Eidos Therapeutics, Inc. Common Stock seller in Q1 2021 was BlackRock, an estimated $205M sold.

Based on aggregated 13F filings for Q1 2021.